GENNIEFY
Market News
Latest financial news and analysis from global markets
INTC
Why Edgewise Therapeutics Stock Topped the Market on Tuesday
One analyst tracking the biotech has become notably more bullish on its future.
NVDA
Should You Buy Best Buy Stock in 2026?
Best Buy is muddling through, and there's no clear sign that things will improve anytime soon.
INTC
Should You Buy Best Buy Stock in 2026?
Best Buy is muddling through, and there's no clear sign that things will improve anytime soon.
NVDA
Nebius Has $46 Billion In Deals And A $28 Billion Market Cap — Do The Math
Nebius Group NV is trading like the math still hasn't caught up to the story: roughly $46 billion in marquee AI infrastructure deals against a market cap just above $28 billion. The $27 Billion Meta Pact Meta Platforms, Inc. has agreed to spend up to $27 billion over five years on Nebius AI infrastructure, one of the largest single AI cloud commitments in the market. The deal, announced Monday, includes $12 billion of dedicated capacity beginning in 2027 and up to $15 billion in additional on‑de
NVDA
This $50 Billion AI Bet Is Either Oracle's Masterstroke or Its Biggest Mistake
Investors have worried about AI spending.
GOOGL
This $50 Billion AI Bet Is Either Oracle's Masterstroke or Its Biggest Mistake
Investors have worried about AI spending.
ORCL
This $50 Billion AI Bet Is Either Oracle's Masterstroke or Its Biggest Mistake
Investors have worried about AI spending.
MSFT
This $50 Billion AI Bet Is Either Oracle's Masterstroke or Its Biggest Mistake
Investors have worried about AI spending.
INTC
Why NFE Stock Just Popped 33.9% -- Then Slumped
NFE is saved, but it comes at a cost.
NVDA
Why NFE Stock Just Popped 33.9% -- Then Slumped
NFE is saved, but it comes at a cost.
NVDA
Should You Sell Tesla Before June 30? Hint: Don't Dare
Investors might be nervous about Tesla's decision to discontinue the Model S and X, but there's much more to be nervous about.
GOOGL
My Nasdaq Stock Picks Have Averaged a 17.9% Return
Five Nasdaq issues that look attractive